Pete Karabas
Board of Directors, Observer @ Front Range Biosciences
Chicago, United States
Pete Karabas is a Series B investor at Front Range Biosciences in Chicago focused on Medical and Cannabis. Pete Karabas is based out of Delray Beach, Florida and is the Founding Partner of KEY Investment Partners. Pete previously worked at Partners Group as a Private Real Estate Group. Pete Karabas attended the University of Wisconsin-Madison. Pete Karabas on Financial & Valuation Modeling.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Pete Karabas invests in
Stages Pete Karabas invests in
Countries Pete Karabas invests in
Investment Focus
Industry
- Medical 1 (33%)
- Cannabis 1 (33%)
- Analytics 1 (33%)
- Agriculture 1 (33%)
- Life Science 1 (33%)
Stage
- Series B 1 (33%)
- Series C 1 (33%)
- Funding Round 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Front Range Biosciences
|
Front Range Biosciences brings modern agriculture to cannabis and hemp to improve reliability, efficiency, and safety for cultivators and consumers. They provide advanced agricultural science services to plant growers. | Aug 27, 2020 | |
|
Front Range Biosciences
|
Front Range Biosciences brings modern agriculture to cannabis and hemp to improve reliability, efficiency, and safety for cultivators and consumers. They provide advanced agricultural science services to plant growers. | $18.7M / Series B / Feb 14, 2020 | |
BDSA
|
BDSA they provides retailers, manufacturers, brands, wholesalers, and investors with actionable insights to drive profitability, increase revenues, and improve stockholdings. | Series C / Aug 20, 2019 |
Co-Investors
Salveo Capital
2 deals together
7thirty Capital
1 deal together
AFI Capital Partners
1 deal together
Altitude Investment Management
1 deal together
Cthulhu Ventures
1 deal together
HALLEY Venture Partners
1 deal together
About Front Range Biosciences
Front Range Biosciences brings modern agriculture to cannabis and hemp to improve reliability, efficiency, and safety for cultivators and consumers. They provide advanced agricultural science services to plant growers.
Front Range Biosciences Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Brad Schwartz
VP of Sales
|
|||
Christopher Zalewski
Co-Founder & CSO
|
|||
Jonathan Vaught
Co-Founder & CEO
|
|||
Nick Hofmeister
Co-Founder & CSO
|
|||
|
Pete Karabas
Board of Directors, Observer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Pete Karabas invest in?
Pete Karabas invests primarily in Medical, Cannabis and Analytics startups, most often at Series B and Series C stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Pete Karabas last invest?
The most recent investment recorded for Pete Karabas closed in Aug 2020. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
